{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:42:29Z","timestamp":1792978949905,"version":"4.5.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Metabolic diseases should always be considered when evaluating children presenting with seizures. This is because many metabolic disorders are potentially treatable and seizure control can be achieved when these diseases are appropriately treated. Seizures caused by underlying metabolic diseases (metabolic seizures) should be particularly considered in unexplained neonatal seizures, refractory seizures, seizures related to fasting or food intake, seizures associated with other systemic or neurologic features, parental consanguinity, and family history of epilepsy. Metabolic seizures can be caused by various amino acids metabolic disorders, disorders of energy metabolism, cofactor-related metabolic diseases, purine and pyrimidine metabolic diseases, congenital disorders of glycosylation, and lysosomal and peroxisomal disorders. Diagnosing metabolic seizures without delay is essential because the immediate initiation of appropriate therapy for many metabolic diseases can prevent or minimize complications.<\/jats:p>","DOI":"10.3389\/fneur.2021.640371","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:54:50Z","timestamp":1625532890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Metabolic Seizures"],"prefix":"10.3389","volume":"12","author":[{"given":"Mohammed","family":"Almannai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabah A.","family":"Al Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mekki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman W.","family":"El-Hattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.pcl.2017.11.007","article-title":"Inborn errors of metabolism with seizures: defects of glycine and serine metabolism and cofactor-related disorders","volume":"65","author":"Almannai","year":"2018","journal-title":"Pediatr Clin North Am."},{"key":"B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1684\/epd.2015.0754","article-title":"Treatable newborn and infant seizures due to inborn errors of metabolism","volume":"17","author":"Campistol","year":"2015","journal-title":"Epileptic Disord Int Epilepsy J Videotape."},{"key":"B3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(14)70110-3","article-title":"Occasional seizures, epilepsy, and inborn errors of metabolism","volume":"13","author":"Dulac","year":"2014","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1469-8749.2012.04406.x","article-title":"Inborn errors of metabolism causing epilepsy","volume":"55","author":"Rahman","year":"2013","journal-title":"Dev Med Child Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.nurt.2010.05.015","article-title":"Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy","volume":"7","author":"Brusilow","year":"2010","journal-title":"Neurotherapeutics."},{"key":"B6","article-title":"Nonketotic hyperglycinemia","volume-title":"GeneReviews\u00ae","author":"Van Hove","year":"1993"},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: Clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Mol Genet Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.31887\/DCNS.2008.10.1\/rjleventer","article-title":"Malformations of cortical development and epilepsy","volume":"10","author":"Leventer","year":"2008","journal-title":"Dialogues Clin Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s10545-009-1171-3","article-title":"Epilepsy and inborn errors of metabolism in children","volume":"32","author":"Wolf","year":"2009","journal-title":"J Inherit Metab Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10545-009-1045-8","article-title":"New treatment paradigms in neonatal metabolic epilepsies","volume":"32","author":"Pearl","year":"2009","journal-title":"J Inherit Metab Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.mayocp.2013.06.012","article-title":"Etiology and therapeutic approach to elevated lactate levels","volume":"88","author":"Andersen","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/gim.2015.186","article-title":"Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy","volume":"18","author":"Helbig","year":"2016","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11910-005-0010-7","article-title":"Seizures and metabolic disease","volume":"5","author":"Pearl","year":"2005","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10545-016-9921-5","article-title":"On the phenotypic spectrum of serine biosynthesis defects","volume":"39","author":"El-Hattab","year":"2016","journal-title":"J Inherit Metab Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ymgme.2016.04.010","article-title":"Serine biosynthesis and transport defects","volume":"118","author":"El-Hattab","year":"2016","journal-title":"Mol Genet Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10545-013-9592-4","article-title":"An update on serine deficiency disorders","volume":"36","author":"van der Crabben","year":"2013","journal-title":"J Inherit Metab Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10545-010-9249-5","article-title":"Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency","volume":"34","author":"Tabatabaie","year":"2011","journal-title":"J Inherit Metab Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1023\/A:1015624726822","article-title":"Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids","volume":"25","author":"De Koning","year":"2002","journal-title":"J Inherit Metab Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/ana.24485","article-title":"Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia","volume":"78","author":"Swanson","year":"2015","journal-title":"Ann Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jmri.23693","article-title":"Neonatal neuroimaging findings in inborn errors of metabolism","volume":"37","author":"Poretti","year":"2013","journal-title":"J Magn Reson Imaging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.20759","article-title":"Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation","volume":"59","author":"Korman","year":"2006","journal-title":"Ann Neurol."},{"key":"B22","article-title":"Maple Syrup Urine Disease","volume-title":"GeneReviews\u00ae","author":"Strauss","year":"2020"},{"key":"B23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymgme.2020.01.006","article-title":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes","volume":"129","author":"Strauss","year":"2020","journal-title":"Mol Genet Metab."},{"key":"B24","article-title":"Urea cycle disorders overview","volume-title":"GeneReviews\u00ae","author":"Ah Mew","year":"2017"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"K\u00f6lker","year":"2015","journal-title":"J Inherit Metab Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2215\/CJN.01320216","article-title":"The role of RRT in hyperammonemic patients","volume":"11","author":"Gupta","year":"2016","journal-title":"Clin J Am Soc Nephrol CJASN."},{"key":"B27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pcl.2017.11.003","article-title":"Inborn errors of metabolism with acidosis: organic acidemias and defects of pyruvate and ketone body metabolism","volume":"65","author":"Schillaci","year":"2018","journal-title":"Pediatr Clin North Am."},{"key":"B28","article-title":"Propionic acidemia","volume-title":"GeneReviews\u00ae","author":"Shchelochkov","year":"1993"},{"key":"B29","article-title":"Isolated methylmalonic acidemia","volume-title":"GeneReviews\u00ae","author":"Manoli","year":"1993"},{"key":"B30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ceca.2016.03.003","article-title":"Mitochondrial cytopathies","volume":"60","author":"El-Hattab","year":"2016","journal-title":"Cell Calcium."},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/07853890.2011.598547","article-title":"Mechanisms of mitochondrial diseases","volume":"44","author":"Ylikallio","year":"2012","journal-title":"Ann Med."},{"key":"B32","volume-title":"Mitochondrial Disorders Overview. GeneReviews\u00ae [Internet]","author":"Chinnery","year":"2014"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.09.009","article-title":"Therapies for mitochondrial diseases and current clinical trials","volume":"122","author":"El-Hattab","year":"2017","journal-title":"Mol Genet Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2020.10.002","article-title":"Clinical trials in mitochondrial disorders, an update","volume":"131","author":"Almannai","year":"2020","journal-title":"Mol Genet Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1440-1754.2006.00852.x","article-title":"Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome","volume":"42","author":"Coman","year":"2006","journal-title":"J Paediatr Child Health."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/j.1528-1167.2012.03592.x","article-title":"Glucose transporter type I deficiency syndrome: Epilepsy phenotypes and outcomes","volume":"53","author":"Pong","year":"2012","journal-title":"Epilepsia."},{"key":"B37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.seizure.2013.07.003","article-title":"GLUT1 deficiency syndrome 2013: Current state of the art","volume":"22","author":"De Giorgis","year":"2013","journal-title":"Seizure."},{"key":"B38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1528-1167.2008.01833.x","article-title":"Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet","volume":"49","author":"Klepper","year":"2008","journal-title":"Epilepsia."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00438-015-1067-x","article-title":"Carrier frequency of guanidinoacetate methyltransferase deficiency in the general population by functional characterization of missense variants in the GAMT gene","volume":"290","author":"Desroches","year":"2015","journal-title":"Mol Genet Genomics."},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymgme.2013.10.018","article-title":"Guanidinoacetate methyltransferase (GAMT) deficiency: Outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring","volume":"111","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Mol Genet Metab."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1891\/9780826168641.0019","article-title":"Pyridoxine-dependent epilepsy","volume-title":"GeneReviews\u00ae","author":"Gospe","year":"2017"},{"key":"B42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2009","journal-title":"Eur J Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain."},{"key":"B44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2020","journal-title":"J Inherit Metab Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1177\/0883073814550829","article-title":"Pyridox(am)ine-5-phosphate oxidase deficiency treatable cause of neonatal epileptic encephalopathy with burst suppression: case report and review of the literature","volume":"30","author":"Guerin","year":"2014","journal-title":"J Child Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jmd2.12183","article-title":"Early-onset vitamin B6-dependent epilepsy due to pathogenic PLPBP variants in a premature infant: A case report and review of the literature","volume":"58","author":"Heath","year":"2021","journal-title":"JIMD Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ajhg.2009.08.005","article-title":"Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism","volume":"85","author":"Steinfeld","year":"2009","journal-title":"Am J Hum Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/brain\/aws122","article-title":"Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency","volume":"135","author":"Grapp","year":"2012","journal-title":"Brain."},{"key":"B50","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpeds.2010.02.027","article-title":"Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry","volume":"157","author":"Tortorelli","year":"2010","journal-title":"J Pediatr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.braindev.2011.05.014","article-title":"Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy","volume":"33","author":"Prasad","year":"2011","journal-title":"Brain Dev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10545-015-9860-6","article-title":"Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency","volume":"39","author":"Huemer","year":"2016","journal-title":"J Inherit Metab Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J Inherit Metab Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1542\/peds.2004-1897","article-title":"isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature","volume":"116","author":"Tan","year":"2005","journal-title":"Pediatrics."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/humu.21390","article-title":"Molybdenum cofactor deficiency: mutations in GPHN, MOCS1, and MOCS2","volume":"32","author":"Reiss","year":"2011","journal-title":"Hum Mutat."},{"key":"B56","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/088307380101600406","article-title":"Molybdenum cofactor deficiency: report of three cases presenting as hypoxic-ischemic encephalopathy","volume":"16","author":"Topcu","year":"2001","journal-title":"J Child Neurol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(15)00124-5","article-title":"Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study","volume":"386","author":"Schwahn","year":"2015","journal-title":"Lancet."},{"key":"B58","article-title":"Biotinidase deficiency","volume-title":"GeneReviews\u00ae","author":"Wolf","year":"1993"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ymgme.2011.06.001","article-title":"The neurology of biotinidase deficiency","volume":"104","author":"Wolf","year":"2011","journal-title":"Mol Genet Metab."},{"key":"B60","article-title":"Disorders of purine and pyrimidine metabolism","volume-title":"Rudolph's Pediatrics","author":"El-Hattab","year":"2018"},{"key":"B61","article-title":"HPRT1 disorders","volume-title":"GeneReviews\u00ae","author":"Jinnah","year":"2020"},{"key":"B62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10545-014-9755-y","article-title":"Adenylosuccinate lyase deficiency","volume":"38","author":"Jurecka","year":"2015","journal-title":"J Inherit Metab Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpeds.2006.09.027","article-title":"Lethal fetal and early neonatal presentation of adenylosuccinate lyase deficiency: observation of 6 patients in 4 families","volume":"150","author":"Mouchegh","year":"2007","journal-title":"J Pediatr."},{"key":"B64","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1023\/B:BOLI.0000037350.24142.d5","article-title":"Head imaging abnormalities in dihydropyrimidine dehydrogenase deficiency","volume":"27","author":"Enns","year":"2004","journal-title":"J Inherit Metab Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.bbadis.2010.03.013","article-title":"Dihydropyrimidinase deficiency: phenotype, genotype and structural consequences in 17 patients","volume":"1802","author":"van Kuilenburg","year":"2010","journal-title":"Biochim Biophys Acta."},{"key":"B66","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pcl.2017.11.011","article-title":"Inborn errors of metabolism involving complex molecules: lysosomal and peroxisomal storage diseases","volume":"65","author":"Bellettato","year":"2018","journal-title":"Pediatr Clin North Am."},{"key":"B67","article-title":"Zellweger spectrum disorder","volume-title":"GeneReviews\u00ae","author":"Steinberg","year":"1993"},{"key":"B68","article-title":"Gaucher disease","volume-title":"GeneReviews\u00ae","author":"Pastores","year":"1993"},{"key":"B69","article-title":"Acid sphingomyelinase deficiency","volume-title":"GeneReviews\u00ae","author":"Wasserstein","year":"1993"},{"key":"B70","article-title":"Niemann-pick disease Type C","volume-title":"GeneReviews\u00ae","author":"Patterson","year":"1993"},{"key":"B71","article-title":"Arylsulfatase A deficiency","volume-title":"GeneReviews\u00ae","author":"Gomez-Ospina","year":"1993"},{"key":"B72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann Transl Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-neuro-071714-034019","article-title":"Neurological aspects of human glycosylation disorders","volume":"38","author":"Freeze","year":"2015","journal-title":"Annu Rev Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/dmcn.13141","article-title":"Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy","volume":"58","author":"Barba","year":"2016","journal-title":"Dev Med Child Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41436-020-0933-z","article-title":"Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation","volume":"22","author":"Rymen","year":"2020","journal-title":"Genet Med Off J Am Coll Med Genet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1093\/hmg\/ddv057","article-title":"Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors","volume":"24","author":"Ng","year":"2015","journal-title":"Hum Mol Genet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.640371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:55:00Z","timestamp":1625532900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.640371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":76,"alternative-id":["10.3389\/fneur.2021.640371"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.640371","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"article-number":"640371"}}